The Gallbladder & Digestive Health Panel evaluates key biomarkers associated with liver function, gallbladder activity, pancreatic enzymes, inflammation, and metabolic health. By combining the Comprehensive Metabolic Panel, GGT, lipase, amylase, CBC, CRP, and a lipid panel, this test provides a broad laboratory assessment of digestive system function and helps support clinical evaluation of symptoms that may involve the liver, pancreas, or biliary system.

The Indican Urine Test measures indican, a byproduct of protein breakdown by intestinal bacteria. Elevated levels may indicate poor digestion, malabsorption, small intestinal bacterial overgrowth (SIBO), or gastrointestinal disorders. Doctors use this test to evaluate gut health, investigate symptoms like bloating, gas, or fatigue, and monitor treatment for digestive imbalances. It provides valuable insight into intestinal function, metabolism, and overall digestive health.

The Amylase Test measures amylase enzyme levels in blood to evaluate pancreatic and digestive health. Elevated amylase may indicate pancreatitis, gallbladder disease, intestinal blockage, or salivary gland disorders, while low levels may suggest chronic pancreatitis or liver damage. Doctors order this test to investigate abdominal pain, nausea, or fever. Results provide vital insight into pancreatic function, digestive disorders, and overall metabolic health.

The Fecal Globin by Immunochemistry Test detects hidden (occult) blood in stool using antibodies that identify human globin protein. This test helps screen for colorectal cancer, polyps, ulcers, and gastrointestinal bleeding. Doctors order it when patients have anemia, abdominal pain, or changes in bowel habits. Results provide early detection of digestive tract bleeding, guiding further evaluation with colonoscopy or other diagnostic procedures.

The Advanced Gallbladder Risk & Metabolic Panel evaluates biomarkers related to liver and gallbladder function, pancreatic enzymes, inflammation, lipid metabolism, glucose regulation, iron stores, and vitamin D status. By combining digestive, metabolic, and cardiometabolic markers including CMP, GGT, lipase, insulin, ApoB, ferritin, and vitamin D, this panel provides a comprehensive laboratory assessment of factors that may influence gallbladder health and metabolic balance.

The Lipase Test measures levels of lipase, an enzyme made by the pancreas that helps digest fats. Elevated lipase may indicate acute or chronic pancreatitis, pancreatic cancer, gallbladder disease, kidney failure, or bowel obstruction. Doctors order this test to investigate severe abdominal pain, nausea, or vomiting and to monitor pancreatic disorders. Results provide vital insight into digestive health, pancreatic function, and overall gastrointestinal balance.

The Nutrient Absorption & Deficiency Panel — Comprehensive evaluates how effectively nutrients are absorbed and utilized by combining digestive, metabolic, and nutritional biomarkers. Measuring pancreatic elastase-1, iron status, vitamins A, B12, D, E, folate, trace minerals, homocysteine, PTH, CBC, and a Comprehensive Metabolic Panel, this test provides an in-depth view of nutrient absorption, deficiency patterns, and metabolic context.

The Glucose Plasma Test measures the amount of glucose in the blood to assess how the body regulates sugar. Abnormal results may indicate diabetes, prediabetes, hypoglycemia, or other metabolic disorders. Doctors order this test for patients with symptoms like fatigue, excessive thirst, or frequent urination. It is also commonly used for routine health screening, monitoring diabetes treatment, and guiding lifestyle or medication adjustments.